| Delirium in the terminally ill. | |
| | |
MedLine Citation:
|
PMID: 10783433 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Delirium is highly prevalent in terminally ill patients, especially in the last weeks of life, when some cognitive impairment develops in as many as 85% of patients. Delirium is associated with increased morbidity in terminally ill patients and can interfere with pain and symptom control. The cause of delirium is usually multifactorial and often cannot be found or reversed in dying patients. Nonpharmacologic and pharmacologic interventions are effective in controlling the symptoms of delirium in terminally ill patients. Haloperidol and other newer neuroleptics are safe and effective in eliminating delirium for some patients. In approximately one third of patients, delirium can be managed successfully only by providing sedation. |
| | |
Authors:
|
W Breitbart; D Strout |
Related Documents
:
|
1274123 - The unified concept of shock. 12697083 - Systemic candida infection in burn patients: a case-control study of management pattern... 1690543 - Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinics in geriatric medicine Volume: 16 ISSN: 0749-0690 ISO Abbreviation: Clin. Geriatr. Med. Publication Date: 2000 May |
Date Detail:
|
Created Date: 2000-06-16 Completed Date: 2000-06-16 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8603766 Medline TA: Clin Geriatr Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 357-72 Citation Subset: IM |
Affiliation:
|
Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antipsychotic Agents
/
therapeutic use Delirium / diagnosis, etiology, prevention & control*, psychology* Diagnosis, Differential Geriatric Assessment Haloperidol / therapeutic use Humans Mass Screening / methods Morbidity Prevalence Risk Factors Terminal Care / methods*, psychology* |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 52-86-8/Haloperidol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Depression and the dying older patient.
Next Document: Palliative care for advanced dementia.